Deutsches Krebsforschungszentrum (DKFZ)

Process Evaluation of a Medical Student-Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized Trial (2019) Brinker TJ, Buslaff F, Suhre JL, Silchmueller MP, Divizieva E, Wilhelm J, Hillebrand G, et al. Journal article Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study (2019) Huang L, Balavarca Y, Van Der Geest L, Lemmens V, Van Eycken L, De Schutter H, Johannesen TB, et al. Journal article Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p (2019) Goeppert B, Truckenmueller F, Ori A, Fritz V, Albrecht T, Fraas A, Scherer D, et al. Journal article Mutation-induced alterations of intra-filament subunit organization in vimentin filaments revealed by SAXS (2019) Brennich ME, Vainio U, Wedig T, Bauch S, Herrmann H, Koester S Journal article Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases (2019) Rauschenberg R, Bruns J, Bruetting J, Daubner D, Lohaus F, Zimmer L, Forschner A, et al. Journal article A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection (2019) Hess J, Unger K, Maihoefer C, Schuettrumpf L, Wintergerst L, Heider T, Weber P, et al. Journal article Chicken GRIFIN: binding partners, developmental course of localization and activation of its lens-specific gene expression by L-Maf/Pax6 (2019) Caballero GG, Schmidt S, Schnoelzer M, Schlötzer-Schrehardt U, Knospe C, Ludwig AK, Manning JC, et al. Journal article Sequence-dependent cross-resistance of combined radiotherapy plus BRAF(V600E) inhibition in melanoma (2019) Shannan B, Matschke J, Chauvistre H, Vogel F, Klein D, Meier F, Westphal D, et al. Journal article Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD (2019) Schlenk RF, Weber D, Fiedler W, Salih HR, Wulf G, Salwender H, Schroeder T, et al. Journal article Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial (2019) Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, et al. Journal article